284 related articles for article (PubMed ID: 18682507)
21. Are biochemical values predictive of adenoma's weight in primary hyperparathyroidism?
Hamidi S; Aslani A; Nakhjavani M; Pajouhi M; Hedayat A; Kamalian N
ANZ J Surg; 2006 Oct; 76(10):882-5. PubMed ID: 17007616
[TBL] [Abstract][Full Text] [Related]
22. Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients.
Krajisnik T; Olauson H; Mirza MA; Hellman P; Akerström G; Westin G; Larsson TE; Björklund P
Kidney Int; 2010 Nov; 78(10):1024-32. PubMed ID: 20686451
[TBL] [Abstract][Full Text] [Related]
23. Elevated parathyroid hormone levels after parathyroidectomy for primary hyperparathyroidism.
Mizrachi A; Gilat H; Bachar G; Feinmesser R; Shpitzer T
Head Neck; 2009 Nov; 31(11):1456-60. PubMed ID: 19405085
[TBL] [Abstract][Full Text] [Related]
24. Coexisting primary hyperparathyroidism and sarcoidosis cause increased angiotensin-converting enzyme and decreased parathyroid hormone and phosphate levels.
Lim V; Clarke BL
J Clin Endocrinol Metab; 2013 May; 98(5):1939-45. PubMed ID: 23493435
[TBL] [Abstract][Full Text] [Related]
25. Non-super-selective venous sampling for persistent hyperparathyroidism using a systemic hypocalcemic challenge.
Morris LF; Loh C; Ro K; Wiseman JE; Gomes AS; Asandra A; Wariri S; Yeh MW
J Vasc Interv Radiol; 2012 Sep; 23(9):1191-9. PubMed ID: 22832137
[TBL] [Abstract][Full Text] [Related]
26. The relationship between adenoma weight and intact (1-84) parathyroid hormone level in primary hyperparathyroidism.
Williams JG; Wheeler MH; Aston JP; Brown RC; Woodhead JS
Am J Surg; 1992 Mar; 163(3):301-4. PubMed ID: 1539763
[TBL] [Abstract][Full Text] [Related]
27. Primary hyperparathyroidism: do perioperative biochemical variables correlate with parathyroid adenoma weight or volume?
Randhawa PS; Mace AD; Nouraei SA; Stearns MP
Clin Otolaryngol; 2007 Jun; 32(3):179-84. PubMed ID: 17550505
[TBL] [Abstract][Full Text] [Related]
28. Decreased parathyroid Klotho expression is associated with persistent hyperparathyroidism after kidney transplantation.
Hong YA; Choi DE; Lim SW; Yang CW; Chang YK
Transplant Proc; 2013 Oct; 45(8):2957-62. PubMed ID: 24157012
[TBL] [Abstract][Full Text] [Related]
29. Parathyroid function and histology in patients with parathyroid adenoma: correlation of clinical and morphologic findings.
Luts L; Bergenfelz A; Alumets J; Sundler F
World J Surg; 1997 Jun; 21(5):553-63. PubMed ID: 9204747
[TBL] [Abstract][Full Text] [Related]
30. Involvement of alpha-klotho and fibroblast growth factor receptor in the development of secondary hyperparathyroidism.
Kumata C; Mizobuchi M; Ogata H; Koiwa F; Nakazawa A; Kondo F; Kadokura Y; Kinugasa E; Akizawa T
Am J Nephrol; 2010; 31(3):230-8. PubMed ID: 20068287
[TBL] [Abstract][Full Text] [Related]
31. Involvement of α-klotho, fibroblast growth factor-, vitamin-D- and calcium-sensing receptor in 53 patients with primary hyperparathyroidism.
Latus J; Lehmann R; Roesel M; Fritz P; Braun N; Ulmer C; Steurer W; Biegger D; Ott G; Dippon J; Alscher MD; Kimmel M
Endocrine; 2013 Aug; 44(1):255-63. PubMed ID: 23334987
[TBL] [Abstract][Full Text] [Related]
32. Different PTH response to oral peptone load and oral calcium load in patients with normocalcemic primary hyperparathyroidism, primary hyperparathyroidism, and healthy subjects.
Invernizzi M; Carda S; Righini V; Baricich A; Cisari C; Bevilacqua M
Eur J Endocrinol; 2012 Oct; 167(4):491-7. PubMed ID: 22872468
[TBL] [Abstract][Full Text] [Related]
33. Diffuse parathyroid hormone expression in parathyroid tumors argues against important functional tumor subclones.
Haglund F; Juhlin CC; Kiss NB; Larsson C; Nilsson IL; Höög A
Eur J Endocrinol; 2016 May; 174(5):583-90. PubMed ID: 26865585
[TBL] [Abstract][Full Text] [Related]
34. Intraoperative secretion of intact parathyroid hormone and amino-terminal parathyroid hormone fragments from normal parathyroid glands associated with solitary parathyroid adenoma.
Bergenfelz A; Ahrén B
World J Surg; 1997 Jan; 21(1):30-4; discussion 34-5. PubMed ID: 8943174
[TBL] [Abstract][Full Text] [Related]
35. Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism.
Kifor O; Moore FD; Wang P; Goldstein M; Vassilev P; Kifor I; Hebert SC; Brown EM
J Clin Endocrinol Metab; 1996 Apr; 81(4):1598-606. PubMed ID: 8636374
[TBL] [Abstract][Full Text] [Related]
36. Hypermethylated in cancer 1 (HIC1), a tumor suppressor gene epigenetically deregulated in hyperparathyroid tumors by histone H3 lysine modification.
Svedlund J; Koskinen Edblom S; Marquez VE; Åkerström G; Björklund P; Westin G
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1307-15. PubMed ID: 22544915
[TBL] [Abstract][Full Text] [Related]
37. Prolactin receptor in primary hyperparathyroidism--expression, functionality and clinical correlations.
Haglund F; Lu M; Vukojević V; Nilsson IL; Andreasson A; Džabić M; Bränström R; Höög A; Juhlin CC; Larsson C
PLoS One; 2012; 7(5):e36448. PubMed ID: 22606260
[TBL] [Abstract][Full Text] [Related]
38. Ex Vivo Intact Tissue Analysis Reveals Alternative Calcium-sensing Behaviors in Parathyroid Adenomas.
Koh J; Zhang R; Roman S; Duh QY; Gosnell J; Shen W; Suh I; Sosa JA
J Clin Endocrinol Metab; 2021 Oct; 106(11):3168-3183. PubMed ID: 34272844
[TBL] [Abstract][Full Text] [Related]
39. Characteristics, management and outcome of primary hyperparathyroidism in South Africa: a single-centre experience.
Paruk IM; Esterhuizen TM; Maharaj S; Pirie FJ; Motala AA
Postgrad Med J; 2013 Nov; 89(1057):626-31. PubMed ID: 23824345
[TBL] [Abstract][Full Text] [Related]
40. 1,25-dihydroxyvitamin D suppresses circulating levels of parathyroid hormone in a patient with primary hyperparathyroidism and coexistent sarcoidosis.
Kinoshita Y; Taguchi M; Takeshita A; Miura D; Tomikawa S; Takeuchi Y
J Clin Endocrinol Metab; 2005 Dec; 90(12):6727-31. PubMed ID: 16159932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
